Dr. Reddy's Laboratories Revenue, Profits - RDY Annual Income Statement

Add to My Stocks
$31.93 $0.44 (1.36%) RDY stock closing price Mar 23, 2018 (Closing)

Looking at financial statements, along with the Dr. Reddy's Laboratories stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for RDY which shows a YOY revenue decline of -7.02% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the Dr. Reddy's Laboratories profit and loss statement for 2017 total to $1B. This line item shows that the operating expenses has increased compared with last year. Also check: Dr. Reddy's Laboratories assets and Dr. Reddy's Laboratories free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Apr - Mar2017201620152014201320122011201020092008
Dr. Reddy's Laboratories Revenues or Net Sales
Cost Of Goods Sold (COGS)963M942M1.01B939M1.02B853M773M755M648M614.63M
Dr. Reddy's Laboratories Gross Profit
Research & Development Expense301M269M280M207M141M116M114M84M79M88.27M
Selling General & Admin Expense699M677M668M622M616M567M532M501M413M379.19M
Income Before Depreciation Depletion Amortization208M447M422M434M355M365M258M223M225M167.41M
Depreciation Depletion Amortization---------40.35M
Non Operating Income29M37M48M10M43M-2M21M-177M-304M-41.15M
Interest Expense12M75M18M-------
Dr. Reddy's Laboratories Pretax Income
Provision for Income Taxes40M108M96M85M90M83M31M22M23M-30.72M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations186M302M356M359M308M280M248M24M-102M116.89M
Extraordinary Items & Discontinued Operations----------
Dr. Reddy's Laboratories Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS167.57M170.62M171.15M170.95M171.11M175.63M165.33M240M170M-
Average Shares used to compute Basic EPS167.57M170.62M171.15M170.95M171.11M175.63M165.33M240M170M-
Income Before Nonrecurring Items186M302M356M351M316M300M242M205M173M117M
Income from Nonrecurring Items---8M-8M-19M6M-181M-275M-
Dr. Reddy's Laboratories Earnings Per Share Basic Net
Dr. Reddy's Laboratories Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items1.111.772.082.051.851.711.460.851.020.69
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Dr. Reddy's Laboratories stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Dr. Reddy's Laboratories revenue chart implies that the company is growing. It has not been the case with Dr. Reddy's Laboratories. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Dr. Reddy's Laboratories try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The RDY financials along with Dr. Reddy's Laboratories historical stock prices provide a lot of details about the firm.

Dr. Reddy's Laboratories Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield

Annual Income Statements - Dr.Reddy's Laboratories Ltd (ADR) Industry Peers

ASPEN PHARMACR income statement, Novartis income statement, Sanofi income statement, Teva Pharmaceutical income statement